Pharma Stocks
-
Assessing Zealand Pharma (CPSE:ZEAL) Valuation After Prolonged Share Price Weakness
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.…
Read More » -
Assessing ANI Pharmaceuticals (ANIP) Valuation After Mixed Share Performance And Cortrophin Gel Growth Prospects
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply…
Read More » -
Recent 3.5% pullback isn’t enough to hurt long-term Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders, they’re still up 64% over 5 years
The simplest way to invest in stocks is to buy exchange traded funds. But in our experience, buying the right…
Read More » -
BridgeBio Pharma (BBIO) Valuation Check After Strong Multi Year Returns And Revenue Growth
BridgeBio Pharma stock reacts to recent performance data BridgeBio Pharma (BBIO) has attracted fresh attention after recent performance figures highlighted…
Read More » -
Torrent Pharma FDA inspection ends with clean chit; co hikes JB Chemicals stake to 48.75%
Torrent Pharmaceuticals Ltd on Friday (January 23) informed that the US Food and Drug Administration (FDA) inspected its Dahej manufacturing…
Read More » -
West Pharmaceutical Sells SmartDose Rights To AbbVie And Refocuses Portfolio
West Pharmaceutical Services (NYSE:WST) has agreed to sell all manufacturing and supply rights for its SmartDose 3.5mL On Body Delivery…
Read More » -
Sun Pharmaceutical Industries Sees Notable Surge in Deriv…
Open Interest and Volume Dynamics On 23 Jan 2026, Sun Pharma’s open interest in futures and options contracts rose sharply…
Read More » -
Pfizer (PFE) Valuation Check As Shares Recover Modestly From Longer Term Weakness
Recent performance snapshot for Pfizer (PFE) Pfizer (PFE) has moved quietly higher in recent months, with a 1-month return of…
Read More » -
Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid …
Technical Trend Overview The pharmaceutical giant’s technical trend has deteriorated from mildly bearish to outright bearish, reflecting increased selling pressure…
Read More » -
60 Degrees Pharma, Runway expand ARAKODA malaria access
60 Degrees Pharmaceuticals (NASDAQ: SXTP) announced a partnership with Runway Health to expand pre-departure access to ARAKODA® (tafenoquine) for malaria…
Read More »